This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
In 2009 we reported the fatal case of a toddler who had received codeine after adenotonsillectomy for obstructive sleep apnea syndrome. The child was an ultra-rapid metabolizer of cytochrome P4502D6 (CYP2D6). We now report 3 additional fatal or life-threatening cases from North America. In the 2 fatal cases, functional gene duplications encoding for CYP2D6 caused a significantly greater production of potent morphine from its parent drug, codeine. A severe case of respiratory depression in an extensive metabolizer is also noted. These cases demonstrate that analgesia with codeine or other opioids that use the CYP2D6 pathway after adenotonsillectomy may not be safe in young children with obstructive sleep apnea syndrome.
- AT —
- adenotonsillectomy
- CNS —
- central nervous system
- CYP2D6 —
- cytochrome P 450 2D6
- EM —
- extensive metabolizer
- OSAS —
- obstructive sleep apnea syndrome
- UM —
- ultra-rapid metabolizer
- Accepted December 6, 2011.
- Copyright © 2012 by the American Academy of Pediatrics
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Purchase access
In this issue
Jump to section
Related Articles
Cited By...
- Pharmacogenomics: An evolving clinical tool for precision medicine
- Guidelines for Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures
- Appropriateness of Pediatrics Case Reports Citations
- Preparing Your Pediatric Patients and Their Families for the Operating Room: Reducing Fear of the Unknown
- Leveraging precision medicine to mitigate medication-safety challenges
- The Interplay between Pharmacokinetics and Pharmacodynamics
- Codeine: Time To Say "No"
- Codeine: Time to Say "No"
- Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease
- Codeine Pharmacogenetics as a Proof of Concept for Pediatric Precision Medicine
- Guidelines for Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures: Update 2016
- Association of National Guidelines With Tonsillectomy Perioperative Care and Outcomes
- A Case of Respiratory Depression in a Child With Ultrarapid CYP2D6 Metabolism After Tramadol
- Practical pharmacokinetics: what do you really need to know?
- The opioid abuse and misuse epidemic: Implications for pharmacists in hospitals and health systems
- Is it farewell to codeine?
- Mu Opioids and Their Receptors: Evolution of a Concept
- FDA warns of risks following codeine use in children